Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02765971
Other study ID # 143
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date May 2016
Est. completion date October 2019

Study information

Verified date September 2019
Source Cairo University
Contact Ahmed Maged
Phone 0020201005227404
Email dr_ahmedmaged@kasralainy.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

540 consented women for being enrolled in this clinical trial and candidates for elective cesarean section will be divided into 3 groups:

- Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.

- Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.

- Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .


Description:

540 consented women for being enrolled in this clinical trial and candidates for elective cesarean section will be divided into 3 groups:

- Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.

- Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.

Group C, 180 women as control group, they will not receive neither gum nor oral fluids. They will be on intravenous fluid. starting oral fluids after hearing intestinal sounds .


Recruitment information / eligibility

Status Recruiting
Enrollment 540
Est. completion date October 2019
Est. primary completion date September 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- all women undergoing elective cesarean section in Kasr Al AI Aini hospital will be candidate for this trial after full explanation of the trial and informed consent to be taken from the women.

Exclusion Criteria:

- cesarean hysterectomy,

- surgical management of severe postpartum hemorrhage

- previous bowel surgery

- women with history of drug consumption,especially opioids

- water and electrolyte disturbances

- pancreatitis or peritonitis

- inability to chew gum

- diabetes, pregnancies accompanied by coagulopathy like pre-eclampsia, hypothyroidism, muscular and neurological disorders

- postoperative admission to intensive care unit

- history of abdominal surgery except cesarean section

- history of postoperative ileus

- patients with drains

Study Design


Related Conditions & MeSH terms

  • Intestinal Recovery After Cesarean Section

Intervention

Other:
gums
Group A, 180 women will receive sugarless gum after their operating room discharge by 3 hours for at least half an hour at two hours interval.
Drug:
picolax drops
Group B, 180 women will receive laxatives after their operating room discharge by 3 hours.
normal saline
Group C received 500 cc of normal saline, Intravenous fluid

Locations

Country Name City State
Egypt Kasr Alainy medical school Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ahmed M Maged, MD

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary appearance of intestinal sounds postoperative evaluated by stethoscope 4-6 hours after CS